Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roledumab vs Polyclonal Anti-D in Healthy RhD-Negative Volunteers
NCT00952575Phase 2Completed
- Sponsor
- LFB Group
- Start
- Aug 2009
- Primary completion
- Jul 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of roledumab in hemolytic disease of the fetus and newborn (HDFN), sponsored by LFB Group. Started Aug 2009; status: completed.
02
Drugs
roledumab
03
Conditions
hemolytic disease of the fetus and newborn (HDFN)
Beyond the preview
Go deeper on NCT00952575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00952575.